Compass Therapeutics (NASDAQ: CMPX) is scheduled to present Phase 2/3 results from a randomized controlled trial of CTX-009, a DLL4 x VEGF-A bispecific antibody, in biliary tract cancer at the ESMO 2026 congress on October 24.
Immatics N.V. (NASDAQ: IMTX) is scheduled to provide a Phase 1/2 clinical data update on IMA402 in solid tumors at the ESMO 2026 congress on October 24.
Trevi Therapeutics (NASDAQ: TRVI) shares closed up 10% at $19.07 after the company announced its leadership team will participate in a series of upcoming industry events centered on its lead candidate, Haduvio.
STAAR Surgical (NASDAQ: STAA) shares closed down 9% at $26.44 even as the company projected preliminary second-quarter 2026 revenue surpassing $90 million, more than double the $44.3 million reported in the same period a year earlier.
Jasper Therapeutics (NASDAQ: JSPR) shares closed up 14% at $0.89 after the company completed an all-stock acquisition of Kira Pharmaceuticals in conjunction with a $132 million private placement.
Cosmos Health (NASDAQ: COSM) shares closed down 16% at $0.23 even as the company continued repurchasing stock under its existing buyback program, acquiring an additional 274,000 shares at a mean price of $0.2554.
Xencor Inc. (NASDAQ: XNCR) shares closed up 17% at $17.47 after the company announced that Phase 1 expansion-cohort data for XmAb819 in advanced clear cell renal cell carcinoma has been selected for a proffered oral presentation at the ESMO 2026 congress, scheduled for October …
Intuitive Surgical (NASDAQ: ISRG) shares closed down 14% at $345.42 after the company reported second-quarter revenue of $2.89 billion, up 19% from a year earlier, driven by higher procedure volumes and continued rollout of its newest surgical platform.
REGENXBIO Inc. (NASDAQ: RGNX) shares closed down 12% at $9.89 after the gene-therapy company finalized the pricing of a $100 million public offering, a financing move that dilutes existing shareholders even as it adds capital to the balance sheet.
US equities ended lower on Friday as a renewed chip-sector sell-off and escalating geopolitical risks weighed on sentiment. The S&P 500 fell 1%, the Nasdaq declined 1.5% and the Dow lost 407 points, with Nvidia, Broadcom, AMD and Intel retreating on concerns that AI …